PLOD1 and cancer: In contrast to the results obtained using PBMCs, hEx16-scDbs inhibited cancer growth at a low Effector/Target cells ratio and, consistent with the hEx16-Dbs, the HL-type domain arrangement displayed higher growth inhibitory effects in comparison to the LH type (Figure 3E).